Revision as of 23:29, 15 January 2025 editAlyInWikiWonderland (talk | contribs)Autopatrolled, Extended confirmed users82,872 edits See also.Tag: Reverted← Previous edit | Latest revision as of 05:17, 16 January 2025 edit undoCitation bot (talk | contribs)Bots5,447,716 edits Alter: issue, title. Add: doi-access, authors 1-1. Removed parameters. Formatted dashes. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Jay8g | Category:CS1 maint: unflagged free DOI | #UCB_Category 15/29 | ||
(9 intermediate revisions by one other user not shown) | |||
Line 20: | Line 20: | ||
| addiction_liability = | | addiction_liability = | ||
| routes_of_administration = | | routes_of_administration = | ||
| class = ]; ] | | class = ]; ]; ] | ||
| ATC_prefix = | | ATC_prefix = | ||
| ATC_suffix = | | ATC_suffix = | ||
Line 51: | Line 51: | ||
| NIAID_ChemDB = | | NIAID_ChemDB = | ||
| PDB_ligand = | | PDB_ligand = | ||
| synonyms = <small>DL</small>-Phenylalaninol; Phenylmethylethanolamine; Benzylethanolamine; <small>DL</small>-Phenylglycinol; PAL-329; PAL329 | | synonyms = <small>DL</small>-Phenylalaninol; Phenylmethylethanolamine; Benzylethanolamine; <small>DL</small>-Phenylglycinol; α-(Hydroxymethyl)phenethylamine; PAL-329; PAL329 | ||
<!-- Chemical data --> | <!-- Chemical data --> | ||
Line 61: | Line 61: | ||
}} | }} | ||
'''Phenylalaninol''' (code name '''PAL-329'''), or '''<small>DL</small>-phenylalaninol''', also known as '''phenylmethylethanolamine''', is a ] and ] (MRA) of the ] family.<ref name="KohutJacobsRothman2017">{{cite journal | vauthors = Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE | title = Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys | journal = Psychopharmacology (Berl) | volume = 234 | issue = |
'''Phenylalaninol''' (code name '''PAL-329'''), or '''<small>DL</small>-phenylalaninol''', also known as '''phenylmethylethanolamine''' or as '''α-(hydroxymethyl)phenethylamine''', is a ] and ] (MRA) of the ] family.<ref name="KohutJacobsRothman2017">{{cite journal | vauthors = Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE | title = Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys | journal = Psychopharmacology (Berl) | volume = 234 | issue = 23–24 | pages = 3455–3465 | date = December 2017 | pmid = 28889212 | pmc = 5747253 | doi = 10.1007/s00213-017-4731-5 | url = }}</ref><ref name="deMouraSherwoodPrisinzano2018">{{cite journal | last1=de Moura | first1=Fernando Barreto | last2=Sherwood | first2=Alexander | last3=Prisinzano | first3=Thomas Edward | last4=Kohut | first4=Stephen John | last5=Bergman | first5=Jack | title=Intravenous Self-Administration of Synthetic Cathinones in Rhesus Monkeys | journal=The FASEB Journal | volume=32 | issue=S1 | date=2018 | issn=0892-6638 | doi=10.1096/fasebj.2018.32.1_supplement.550.3 | page=| doi-access=free }}</ref> It is related to the ] ] and to the phenethylamine psychostimulants ] (phenylethylamine) and ] (α-methylphenethylamine).<ref name="PubChem" /> | ||
<small>D</small>-Phenylalanine is a psychostimulant and ]-preferring ] (NDRA).<ref name="KohutJacobsRothman2017" /><ref name="deMouraSherwoodPrisinzano2018" /> The {{Abbrlink|EC<sub>50</sub>|half-maximal effective concentration}} values of <small>D</small>-phenylalanine for monoamine release are 106{{nbsp}}nM for norepinephrine, 1,355{{nbsp}}nM for ], and >10,000{{nbsp}}nM for ] in rat brain ]s.<ref name="KohutJacobsRothman2017" /> |
<small>D</small>-Phenylalanine is a psychostimulant and ] ] (NRA) or ]-preferring ] (NDRA).<ref name="KohutJacobsRothman2017" /><ref name="deMouraSherwoodPrisinzano2018" /> The {{Abbrlink|EC<sub>50</sub>|half-maximal effective concentration}} values of <small>D</small>-phenylalanine for monoamine release are 106{{nbsp}}nM for norepinephrine, 1,355{{nbsp}}nM for ], and >10,000{{nbsp}}nM for ] in rat brain ]s.<ref name="KohutJacobsRothman2017" /> It is dramatically less ] as an MRA than phenethylamine or amphetamine.<ref name="KohutJacobsRothman2017" /><ref name="Blough2008">{{cite book | vauthors = Blough B | chapter = Dopamine-releasing agents | veditors = Trudell ML, Izenwasser S | title = Dopamine Transporters: Chemistry, Biology and Pharmacology | pages = 305–320 | date = July 2008 | isbn = 978-0-470-11790-3 | oclc = 181862653 | ol = OL18589888W | publisher = Wiley | location = Hoboken | doi = | url = https://books.google.com/books?id=QCagLAAACAAJ | chapter-url = https://bitnest.netfirms.com/external/Books/Dopamine-releasing-agents_c11.pdf }}</ref> The potency of <small>D</small>-phenylalaninol in inducing norepinephrine release is 13-fold higher than its potency in inducing dopamine release.<ref name="KohutJacobsRothman2017" /> Similarly to other ]s like amphetamine, the drug shows ]-like effects and ] properties in ]s.<ref name="KohutJacobsRothman2017" /><ref name="deMouraSherwoodPrisinzano2018" /> The much greater potency of <small>D</small>-phenylalanine in inducing norepinephrine over inducing dopamine release does not appear to interfere with its dopamine release-mediated reinforcing effects.<ref name="KohutJacobsRothman2017" /><ref name="deMouraSherwoodPrisinzano2018" /> | ||
The clinically used stimulant, ], and ] (NDRI) ] (brand name Sunosi; ''O''-carbamoyl-<small>D</small>-phenylalaninol) is a ] of phenylalaninol with a ] ] at the ] of the molecule.<ref name="YangGao2019">{{cite journal | vauthors = Yang J, Gao J | title = Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy | journal = Expert Rev Clin Pharmacol | volume = 12 | issue = 8 | pages = 723–728 | date = August 2019 | pmid = 31215815 | doi = 10.1080/17512433.2019.1632705 | url = }}</ref> Phenylalaninol is a known ] in ] of solriamfetol.<ref name="FejősTóthVárnai2021">{{cite journal | vauthors = Fejős I, Tóth G, Várnai B, Szabó ZI, Köteles I, Malanga M, Béni S | title = Enantioseparation of solriamfetol and its major impurity phenylalaninol by capillary electrophoresis using sulfated gamma cyclodextrin | journal = Electrophoresis | volume = 42 | issue = |
The clinically used stimulant, ], and well-balanced ] (NDRI) ] (brand name Sunosi; ''O''-carbamoyl-<small>D</small>-phenylalaninol) is a ] of phenylalaninol with a ] ] at the ] of the molecule.<ref name="YangGao2019">{{cite journal | vauthors = Yang J, Gao J | title = Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy | journal = Expert Rev Clin Pharmacol | volume = 12 | issue = 8 | pages = 723–728 | date = August 2019 | pmid = 31215815 | doi = 10.1080/17512433.2019.1632705 | url = }}</ref> Phenylalaninol is a known ] in ] of solriamfetol.<ref name="FejősTóthVárnai2021">{{cite journal | vauthors = Fejős I, Tóth G, Várnai B, Szabó ZI, Köteles I, Malanga M, Béni S | title = Enantioseparation of solriamfetol and its major impurity phenylalaninol by capillary electrophoresis using sulfated gamma cyclodextrin | journal = Electrophoresis | volume = 42 | issue = 17–18 | pages = 1818–1825 | date = September 2021 | pmid = 34109644 | doi = 10.1002/elps.202100076 | url = }}</ref> | ||
The predicted ] of phenylalaninol is 0.7 to 0.77 and hence it is relatively ].<ref name="PubChem">{{cite web | title=DL-Phenylalaninol | website=PubChem | url=https://pubchem.ncbi.nlm.nih.gov/compound/76652 | access-date=15 January 2025}}</ref><ref name="ChemSpider">{{cite web | title=phenylalaninol | website=ChemSpider | date=10 June 2024 | url=https://www.chemspider.com/Chemical-Structure.69116.html | access-date=15 January 2025}}</ref> The compound appears to be ] in the body by some of the same ]s that transport phenylalanine, such as ].<ref name="ShimomuraFukushimaDanno1975">{{cite journal | vauthors = Shimomura K, Fukushima T, Danno T, Matsumoto K, Miyoshi M | title = Inhibition of intestinal absorption of phenylalanine by phenylalaninol | journal = J Biochem | volume = 78 | issue = 2 | pages = 269–275 | date = August 1975 | pmid = 1228171 | doi = 10.1093/oxfordjournals.jbchem.a130904 | url = }}</ref><ref name="BabuKanaiChairoungdua2003">{{cite journal | vauthors = Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H | title = Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters | journal = J Biol Chem | volume = 278 | issue = 44 | pages = 43838–45 | date = October 2003 | pmid = 12930836 | doi = 10.1074/jbc.M305221200 | url = }}</ref> | The predicted ] of phenylalaninol is 0.7 to 0.77 and hence it is relatively ].<ref name="PubChem">{{cite web | title=DL-Phenylalaninol | website=PubChem | url=https://pubchem.ncbi.nlm.nih.gov/compound/76652 | access-date=15 January 2025}}</ref><ref name="ChemSpider">{{cite web | title=phenylalaninol | website=ChemSpider | date=10 June 2024 | url=https://www.chemspider.com/Chemical-Structure.69116.html | access-date=15 January 2025}}</ref> The compound appears to be ] in the body by some of the same ]s that transport phenylalanine, such as ].<ref name="ShimomuraFukushimaDanno1975">{{cite journal | vauthors = Shimomura K, Fukushima T, Danno T, Matsumoto K, Miyoshi M | title = Inhibition of intestinal absorption of phenylalanine by phenylalaninol | journal = J Biochem | volume = 78 | issue = 2 | pages = 269–275 | date = August 1975 | pmid = 1228171 | doi = 10.1093/oxfordjournals.jbchem.a130904 | url = }}</ref><ref name="BabuKanaiChairoungdua2003">{{cite journal | vauthors = Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H | title = Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters | journal = J Biol Chem | volume = 278 | issue = 44 | pages = 43838–45 | date = October 2003 | pmid = 12930836 | doi = 10.1074/jbc.M305221200 | doi-access = free | url = }}</ref> | ||
==See also== | |||
* ] | |||
==References== | ==References== | ||
Line 82: | Line 79: | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | |||
Latest revision as of 05:17, 16 January 2025
Not to be confused with Phenylalanine. Pharmaceutical compoundClinical data | |
---|---|
Other names | DL-Phenylalaninol; Phenylmethylethanolamine; Benzylethanolamine; DL-Phenylglycinol; α-(Hydroxymethyl)phenethylamine; PAL-329; PAL329 |
Drug class | Psychostimulant; Norepinephrine releasing agent; Norepinephrine–dopamine releasing agent |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C9H13NO |
Molar mass | 151.209 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Phenylalaninol (code name PAL-329), or DL-phenylalaninol, also known as phenylmethylethanolamine or as α-(hydroxymethyl)phenethylamine, is a psychostimulant and monoamine releasing agent (MRA) of the phenethylamine family. It is related to the amino acid phenylalanine and to the phenethylamine psychostimulants β-phenethylamine (phenylethylamine) and amphetamine (α-methylphenethylamine).
D-Phenylalanine is a psychostimulant and selective norepinephrine releasing agent (NRA) or norepinephrine-preferring norepinephrine–dopamine releasing agent (NDRA). The EC50Tooltip half-maximal effective concentration values of D-phenylalanine for monoamine release are 106 nM for norepinephrine, 1,355 nM for dopamine, and >10,000 nM for serotonin in rat brain synaptosomes. It is dramatically less potent as an MRA than phenethylamine or amphetamine. The potency of D-phenylalaninol in inducing norepinephrine release is 13-fold higher than its potency in inducing dopamine release. Similarly to other dopamine releasers like amphetamine, the drug shows cocaine-like effects and reinforcing properties in rhesus monkeys. The much greater potency of D-phenylalanine in inducing norepinephrine over inducing dopamine release does not appear to interfere with its dopamine release-mediated reinforcing effects.
The clinically used stimulant, wakefulness-promoting agent, and well-balanced norepinephrine–dopamine reuptake inhibitor (NDRI) solriamfetol (brand name Sunosi; O-carbamoyl-D-phenylalaninol) is a derivative of phenylalaninol with a carbamoyl substitution at the hydroxyl group of the molecule. Phenylalaninol is a known impurity in chemical synthesis of solriamfetol.
The predicted log P of phenylalaninol is 0.7 to 0.77 and hence it is relatively hydrophilic. The compound appears to be actively transported in the body by some of the same transporters that transport phenylalanine, such as LAT3.
References
- ^ Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE (December 2017). "Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys". Psychopharmacology (Berl). 234 (23–24): 3455–3465. doi:10.1007/s00213-017-4731-5. PMC 5747253. PMID 28889212.
- ^ de Moura, Fernando Barreto; Sherwood, Alexander; Prisinzano, Thomas Edward; Kohut, Stephen John; Bergman, Jack (2018). "Intravenous Self-Administration of Synthetic Cathinones in Rhesus Monkeys". The FASEB Journal. 32 (S1). doi:10.1096/fasebj.2018.32.1_supplement.550.3. ISSN 0892-6638.
- ^ "DL-Phenylalaninol". PubChem. Retrieved 15 January 2025.
- Blough B (July 2008). "Dopamine-releasing agents" (PDF). In Trudell ML, Izenwasser S (eds.). Dopamine Transporters: Chemistry, Biology and Pharmacology. Hoboken : Wiley. pp. 305–320. ISBN 978-0-470-11790-3. OCLC 181862653. OL 18589888W.
- Yang J, Gao J (August 2019). "Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy". Expert Rev Clin Pharmacol. 12 (8): 723–728. doi:10.1080/17512433.2019.1632705. PMID 31215815.
- Fejős I, Tóth G, Várnai B, Szabó ZI, Köteles I, Malanga M, Béni S (September 2021). "Enantioseparation of solriamfetol and its major impurity phenylalaninol by capillary electrophoresis using sulfated gamma cyclodextrin". Electrophoresis. 42 (17–18): 1818–1825. doi:10.1002/elps.202100076. PMID 34109644.
- "phenylalaninol". ChemSpider. 10 June 2024. Retrieved 15 January 2025.
- Shimomura K, Fukushima T, Danno T, Matsumoto K, Miyoshi M (August 1975). "Inhibition of intestinal absorption of phenylalanine by phenylalaninol". J Biochem. 78 (2): 269–275. doi:10.1093/oxfordjournals.jbchem.a130904. PMID 1228171.
- Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H (October 2003). "Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters". J Biol Chem. 278 (44): 43838–45. doi:10.1074/jbc.M305221200. PMID 12930836.
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |